Evidence map›Paper›PMID 28970455›Full record

ReviewPharmacy (Basel, Switzerland)2017

Development of Pharmacy Practice in European Countries-The Polish Perspective.

Damian Świeczkowski, Piotr Merks, Natalia Cwalina, Miłosz J Jaguszewski

Abstract readReview
In one paragraph

Review in Pharmacy (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Role and impact of pharmacists in Spain: a scoping review.International journal of clinical pharmacy · 2018
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Damian ŚwieczkowskiFirst Department of Cardiology, Medical University in Gdansk, Dębinki 7, 80-952 Gdańsk, Poland. d.swieczkowski@gumed.edu.pl.ORCID 0000-0002-5648-4652
Piotr MerksDepartment of Pharmaceutical Technology, Faculty of Pharmacy Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Dr. A. Jurasza 2, 85-089 Bydgoszcz, Poland. piotrmerks@gmail.com.
Natalia CwalinaFirst Department of Cardiology, Medical University in Gdansk, Dębinki 7, 80-952 Gdańsk, Poland. ncwalina@gumed.edu.pl.
Miłosz J JaguszewskiFirst Department of Cardiology, Medical University in Gdansk, Dębinki 7, 80-952 Gdańsk, Poland. mjaguszewski@gumed.edu.pl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polish pharmacy practice and the distribution of medicinal products in some European countries are still going through a significant transformation. Changes postulated by the pharmacists should strengthen their role, and the place of community pharmacies in the health care system in the context of-among others-the introduction and popularization of pharmaceutical care. Subsequently, these efforts may essentially ensure the professional independence of the pharmacists. The introduction of pharmaceutical care to the pharmacy practice in all European countries will help to improve the quality of patient care and treatment outcomes, and will lead to a better allocation of available resources. Herewith, we present an important voice in the international debate, showing the current changes in the pharmacy practice in Poland, a European Union (EU)-member from 2004. Indeed, this paper presents the perspective of the country in which the position of pharmaceutical care is not well-established, and the role of the pharmacist is still limited to dispensing medicinal products, more than decade after it joined EU.

Indexed as

community pharmacypharmaceutical carepharmaceutical lawpharmacistpharmacy practice

Identifiers

PMID28970455
PMCPMC5622355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.